Mark Dybul

Mark Dybul

Chief Executive Officer bij RENOVARO INC.

Vermogen: 176 175 $ op 31-03-2024

60 jaar
Commercial Services
Health Technology
Health Services

Profiel

Mark Richard Dybul is currently the Executive Vice Chairman & Chief Executive Officer at Renovaro, Inc. He is also the Director at the Elton John AIDS Foundation, Inc., the International AIDS Vaccine Initiative, Inc., and the Elton John AIDS Foundation.
Additionally, he serves as the Faculty Co-Director & Professor at Georgetown University Medical Center and as a Director at Big Win Philanthropy and the National Academy of Medicine.
In the past, Dr. Dybul has worked as the Director of the Elizabeth Glaser Pediatric AIDS Foundation, the Executive Director of Management Sciences for Health, Inc., and the Executive Director of The Global Fund to Fight AIDS, Tuberculosis & Malaria.
He has also held positions as the Director of the National Institute of Allergy & Infectious Diseases, the Director of the Catholic Medical Mission Board, Inc., and the Director & Chief Medical Officer of the United States President's Emergency Plan for AIDS Relief.
Additionally, he served as the Co-Director-Global Health Law Program at the O'Neill Institute For National & Global Health Law.
Dr. Dybul obtained his undergraduate degree from Georgetown University School of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
13-02-2024 66 481 ( 0.05% ) 176 175 $ 31-03-2024

Actieve functies van Mark Dybul

BedrijvenFunctieBegin
RENOVARO INC. Chief Executive Officer 20-07-2021
Georgetown University Medical Center Corporate Officer/Principal 01-06-2017
Director/Board Member -
Director/Board Member -
Director/Board Member -
National Academy of Medicine Corporate Officer/Principal -
Director/Board Member -
Alle actieve functies van Mark Dybul

Eerdere bekende functies van Mark Dybul

BedrijvenFunctieEinde
The Global Fund to Fight AIDS, Tuberculosis & Malaria Director/Board Member 01-05-2017
O'Neill Institute For National & Global Health Law Director/Board Member 01-01-2012
░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░ ░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Ervaring van Mark Dybul in detail bekijken

Opleiding van Mark Dybul

Georgetown University School of Medicine Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Dybul in detail bekijken

Connecties

99

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
RENOVARO INC.

Health Technology

Bedrijven in privébezit12

Commercial Services

Commercial Services

Health Technology

Health Services

The Global Fund to Fight AIDS, Tuberculosis & Malaria

Commercial Services

National Institute of Allergy & Infectious Diseases

Government

Commercial Services

National Academy of Medicine

Commercial Services

Health Services

Commercial Services

O'Neill Institute For National & Global Health Law

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Dybul